North America And Europe Preclinical Medical Device Testing Services Market Size, Share & Trends Analysis Report By Service, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity Flow Analysis
  • 1.6.2. Bottom-up Approach
• 1.7. List of Secondary Sources
• 1.8. List of Abbreviations
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. North America and Europe Preclinical Medical Device Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Complexity in product design
    • 3.2.1.2. Strict approval norms
    • 3.2.1.3. Increase in number of small medical device lacking in-house testing capabilities
    • 3.2.1.4. Intense competition in medical device industry
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Legal and Regulatory Issues
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. North America and Europe Preclinical Medical Device Testing Services Market: Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. North America and Europe Preclinical Medical Device Testing Services Market; Method Movement Analysis
• 4.3. North America and Europe Preclinical Medical Device Testing Services Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
• 4.4. Biocompatibility Tests
  • 4.4.1. Biocompatibility tests market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Chemistry Test
  • 4.5.1. Chemistry test market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Microbiology & Sterility Testing
  • 4.6.1. Microbiology & sterility testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Bioburden Determination
    • 4.6.2.1. Bioburden determination market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Pyrogen & Endotoxin Testing
    • 4.6.3.1. Pyrogen & endotoxin testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Sterility Test and Validation
    • 4.6.4.1. Sterility test and validation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.2. Ethylene Oxide (EO) gas sterilization
      • 4.6.4.2.1. Ethylene oxide (EO) gas sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.3. Gamma-irradiation
      • 4.6.4.3.1. Gamma-irradiation market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.4. E-beam sterilization
      • 4.6.4.4.1. E-beam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4.5. X-ray sterilization
      • 4.6.4.5.1. X-ray sterilization market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.5. Antimicrobial Activity Testing
    • 4.6.5.1. Antimicrobial activity testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Package Validation
  • 4.7.1. Package validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Preclinical Medical Device Testing Services Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. North America
  • 5.3.1. North America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.3.2. U.S.
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Competitive scenario
    • 5.3.2.3. Regulatory framework
    • 5.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Canada
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Competitive scenario
    • 5.3.3.3. Regulatory framework
    • 5.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Mexico
    • 5.3.4.1. Key country dynamics
    • 5.3.4.2. Competitive scenario
    • 5.3.4.3. Regulatory framework
    • 5.3.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.4.2. UK
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Competitive scenario
    • 5.4.2.3. Regulatory framework
    • 5.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Germany
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Competitive scenario
    • 5.4.3.3. Regulatory framework
    • 5.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. France
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Competitive scenario
    • 5.4.4.3. Regulatory framework
    • 5.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Italy
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Competitive scenario
    • 5.4.5.3. Regulatory framework
    • 5.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Spain
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Competitive scenario
    • 5.4.6.3. Regulatory framework
    • 5.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Denmark
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Competitive scenario
    • 5.4.7.3. Regulatory framework
    • 5.4.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Sweden
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Competitive scenario
    • 5.4.8.3. Regulatory framework
    • 5.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.9. Norway
    • 5.4.9.1. Key country dynamics
    • 5.4.9.2. Competitive scenario
    • 5.4.9.3. Regulatory framework
    • 5.4.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Company Market Position Analysis, 2023
• 6.3. Company Profiles
  • 6.3.1. SGS SA
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Service benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. Toxikon, Inc.
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Service benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Eurofins Scientific
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Service benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Pace Analytical Services LLC
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Service benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Intertek Group Plc
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Service benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. WUXI APPTEC
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Service benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. TUV SUD AG
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Service benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Sterigenics International LLC
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Service benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Nelson Labs
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Service benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. North American Science Associates, Inc.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Service benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. American Preclinical Services
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Service benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. Charles River Laboratories International, Inc.
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Service benchmarking
    • 6.3.12.4. Strategic initiatives

List of Tables

• Table 1 List of Tables
• Table 2 List of Secondary Sources
• Table 3 List of Abbreviations
• Table 4 North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 5 North America and Europe Preclinical Medical Device Testing Services Market, by Region, 2018 - 2030 (USD Million)
• Table 6 North America North America and Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 7 North America North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 8 U.S North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 9 Canada North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 10 Mexico North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 11 Europe North America and Europe Preclinical Medical Device Testing Services Market, by Country, 2018 - 2030 (USD Million)
• Table 12 Europe North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 13 UK North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 14 Germany North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 15 France North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 16 Italy North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 17 Spain North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 18 Denmark North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 19 Sweden North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)
• Table 20 Norway North America and Europe Preclinical Medical Device Testing Services Market, by Service, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for Market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 North America and Europe Preclinical Medical Device Testing Services Market revenue, 2018 - 2030 (USD Million)
• Fig. 10 North America and Europe Preclinical Medical Device Testing Services Market snapshot
• Fig. 11 North America and Europe Preclinical Medical Device Testing Services Market driver impact
• Fig. 12 North America and Europe Preclinical Medical Device Testing Services Market restraint impact
• Fig. 13 North America and Europe Preclinical Medical Device Testing Services Market: Service takeaways (USD Million)
• Fig. 14 North America and Europe Preclinical Medical Device Testing Services Market: Service movement analysis
• Fig. 15 Biocompatibility Tests Market, 2018 - 2030 (USD Million)
• Fig. 16 Chemistry Test Market, 2018 - 2030 (USD Million)
• Fig. 17 Microbiology & Sterility Testing Market, 2018 - 2030 (USD Million)
• Fig. 18 Bioburden Determination Market, 2018 - 2030 (USD Million)
• Fig. 19 Pyrogen & Endotoxin Testing Market, 2018 - 2030 (USD Million)
• Fig. 20 Sterility Test and Validation Market, 2018 - 2030 (USD Million)
• Fig. 21 Ethylene Oxide (EO) gas sterilization Market, 2018 - 2030 (USD Million)
• Fig. 22 Gamma-irradiation Market, 2018 - 2030 (USD Million)
• Fig. 23 E-beam sterilization Market, 2018 - 2030 (USD Million)
• Fig. 24 X-ray sterilization Market, 2018 - 2030 (USD Million)
• Fig. 25 Antimicrobial Activity Testing Market, 2018 - 2030 (USD Million)
• Fig. 26 Others Market, 2018 - 2030 (USD Million)
• Fig. 27 Package Validation Market, 2018 - 2030 (USD Million)
• Fig. 28 Regional Marketplace: Key takeaways
• Fig. 29 Regional outlook, 2024 & 2030
• Fig. 30 North America North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 32 Canada North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 33 Mexico North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 34 Europe North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 35 UK North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 36 Germany North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 37 France North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 38 Italy North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 39 Spain companion animal Health Market, 2018 - 2030 (USD Million)
• Fig. 40 Sweden North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 41 Denmark North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 42 Norway North America and Europe Preclinical Medical Device Testing Services Market, 2018 - 2030 (USD Million)
• Fig. 43 Market participant categorization